Biotech investor set to lead US National Science Foundation
• Email Bluesky Facebook LinkedIn Reddit Whatsapp X Jim O’Neill, a biotechnology investor who has held other positions in government, will be appointed by US President Donald Trump
Biotech
Biotech investor set to lead US National Science Foundation
• Email Bluesky Facebook LinkedIn Reddit Whatsapp X Jim O’Neill, a biotechnology investor who has held other positions in government, will be appointed by US President Donald Trump
Biotech Startup M&A Is Reliably Delivering Some Big Exits
• Over past two years, biotech M&A exceeded $38B, surpassing many historic tech exits. • 2026 kickoff: Eli Lilly to pay up to $2.4B for Orna Therapeutics, boosting in‑vivo cell the
Rhododendron-derived drugs now made by bacteria
• E. coli engineered to synthesize rhododendron-derived compounds with anticancer, anti-HIV, antidiabetic, anti-inflammatory properties. • Kobe University’s rational design strateg